Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor IIIGF-II production

被引:33
作者
Lee, Seung Koo [1 ,2 ]
Kang, Jae Seung [1 ,2 ]
Jung, Da Jung [1 ,2 ,4 ]
Hur, Dae Young [3 ]
Kim, Jee Eun [1 ,2 ]
Hahm, Eunsil [1 ,2 ]
Bae, Seyeon [1 ,2 ]
Kim, Hyung Woo [5 ]
Kim, Daejin [1 ,2 ]
Cho, Byung Joo [6 ]
Cho, Daeho [7 ,8 ]
Shin, Dong Hoon [1 ,2 ]
Hwang, Young-Il [1 ,2 ]
Lee, Wang Jae [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110799, South Korea
[2] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, Seoul 110799, South Korea
[3] Inje Univ, Coll Med, Dept Anat, Pusan, South Korea
[4] Inje Univ, Coll Med, Res Ctr Womens Dis, Pusan, South Korea
[5] Dongshin Univ, Coll Oriental Med, Dept Herbol, Naju, South Korea
[6] Konkuk Univ, Konkuk Univ Hosp, Sch Med, Dept Ophthalmol, Seoul, South Korea
[7] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea
[8] Sookmyung Womens Univ, Res Ctr Womens Dis, Seoul, South Korea
关键词
D O I
10.1002/jcp.21391
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vitamin C plays a crucial role in the suppression of proliferation of several types of cancer. Over-expression of cyclooxygenase (COX)-2 and type I insulin-like growth factor (IGF) receptor are important for proliferation and protection from apoptosis in malignancies. However, its specific mechanisms, especially the interaction between COX-2 expression and IGF-I axis mediated by vitamin C, remain yet to be clarified. Therefore, we investigated the effects of vitamin C on the proliferation of melanoma cells via the modulation of COX-2 expression and IGF-I axis. As a result, we found that 1.0 mM vitamin C inhibits the proliferation of SK-MEL-2 without induction of apoptosis. At that moment, IGF-II production was decreased, followed by the inhibition of COX-2 activity. IGF-IR expression was also down-regulated by vitamin C treatment. It coincided with the result from the inhibition of COX-2 by NS-398 and COX-2 siRNA. In addition, the decreased IGF-IR expression by vitamin C was restored by the treatment of recombinant prostaglandin E2. Finally, we determined whether the signal pathway would be involved in vitamin C-induced IGF-II and IGF-IR down-regulation. When the cells were exposed to SB203580, a specific inhibitor of p38 MAPK, COX-2 expression was dramatically recovered. In addition, phosphorylated p38 MAPK was increased after vitamin C treatment. Taken together, vitamin C suppresses proliferation of the human melanoma cell line SK-MEL2 via the down-regulation of IGF-II production and IGF-IR expression, which is followed by the activation of p38 MAPK and the inhibition of COX-2 expression.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 65 条
[1]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[2]  
BASERGA R, 1995, CANCER RES, V55, P249
[3]   The IGF-I receptor in cancer research [J].
Baserga, R .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :1-6
[4]   The IGF-I receptor in cell growth, transformation and apoptosis [J].
Baserga, R ;
Hongo, A ;
Rubini, M ;
Prisco, M ;
Valentinis, B .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1332 (03) :F105-F126
[5]   The contradictions of the insulin-like growth factor 1 receptor [J].
Baserga, R .
ONCOGENE, 2000, 19 (49) :5574-5581
[6]   The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells - Dependence on the availability of downstream targets [J].
Bornfeldt, KE ;
Campbell, JS ;
Koyama, H ;
Argast, GM ;
Leslie, CC ;
Raines, EW ;
Krebs, EG ;
Ross, R .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (04) :875-885
[7]   Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase [J].
Bowie, AG ;
O'Neill, LAJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :7180-7188
[8]   VITAMIN-C PREFERENTIAL TOXICITY FOR MALIGNANT-MELANOMA CELLS [J].
BRAM, S ;
FROUSSARD, P ;
GUICHARD, M ;
JASMIN, C ;
AUGERY, Y ;
SINOUSSIBARRE, F ;
WRAY, W .
NATURE, 1980, 284 (5757) :629-631
[9]   Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells [J].
Cho, D ;
Hahm, E ;
Kang, JS ;
Kim, YI ;
Yang, Y ;
Park, JH ;
Kim, D ;
Kim, SH ;
Kim, YS ;
Hur, DY ;
Park, H ;
Pang, S ;
Hwang, YI ;
Lee, WJ .
MELANOMA RESEARCH, 2003, 13 (06) :549-554
[10]   THE INSULIN-LIKE GROWTH-FACTORS [J].
COHICK, WS ;
CLEMMONS, DR .
ANNUAL REVIEW OF PHYSIOLOGY, 1993, 55 :131-153